Related Experiment Video
Updated: Apr 16, 2026

Examining the Dynamics of Cellular Adhesion and Spreading of Epithelial Cells on Fibronectin During Oxidative Stress
Published on: October 13, 2019
Both mTORC1 and mTORC2 are involved in the regulation of cell adhesion
Long Chen1,2, Baoshan Xu2, Lei Liu2
1Jiangsu Key Laboratory for Microbes and Functional Genomics, Jiangsu Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing 210023, P. R. China.
Abstract:
mTOR is a central controller for cell growth/proliferation and survival. Recent studies have shown that mTOR also regulates cell adhesion, yet the underlying mechanism is not known. Here we found that inhibition of mTOR by rapamycin reduced the basal or type I insulin-like growth factor (IGF-1)-stimulated adhesion of cancer cells. Further research revealed that both mTORC1 and mTORC2 were involved in the regulation of cell adhesion, as silencing expression of raptor or rictor inhibited cell adhesion. Also, PP242, an mTORC1/2 kinase inhibitor, inhibited cell adhesion more potently than rapamycin (mTORC1 inhibitor). Of interest, ectopic expression of constitutively active and rapamycin-resistant mutant of p70 kinase 1 (S6K1) or downregulation of eukaryotic initiation factor 4E (eIF4E)-binding protein 1 (4E-BP1) conferred resistance to rapamycin inhibition of cell adhesion, whereas expression of constitutively hypophosphorylated 4E-BP1 (4EBP1-5A) or downregulation of S6K1 suppressed cell adhesion. In contrast, neither genetic manipulation of Akt activity nor pharmacological inhibition of Akt affected cell adhesion. The results suggest that both mTORC1 and mTORC2 are involved in the regulation of cell adhesion; and mTORC1 regulates cell adhesion through S6K1 and 4E-BP1 pathways, but mTORC2 regulates cell adhesion via Akt-independent mechanism.
Insights
The mechanistic target of rapamycin (mTOR) pathway regulates cancer cell adhesion. Both mTORC1 and mTORC2 complexes are involved, with mTORC1 signaling through S6K1 and 4E-BP1, and mTORC2 acting independently of Akt.
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- The mechanistic target of rapamycin (mTOR) is a key regulator of cell growth, proliferation, and survival.
- Emerging evidence suggests mTOR's involvement in cell adhesion, but the underlying molecular mechanisms remain unclear.
Purpose of the Study:
- To elucidate the role and mechanisms of mTOR in regulating cancer cell adhesion.
- To determine the specific contributions of mTORC1 and mTORC2 complexes to cell adhesion regulation.
Main Methods:
- Inhibition of mTOR signaling using rapamycin and PP242.
- Genetic manipulation including silencing of raptor/rictor, ectopic expression of S6K1/4E-BP1 mutants, and Akt manipulation.
- Assessment of basal and IGF-1-stimulated cancer cell adhesion.
Main Results:
- mTOR inhibition by rapamycin reduced cancer cell adhesion.
- Both mTORC1 and mTORC2 complexes were implicated, as evidenced by reduced adhesion upon raptor/rictor silencing.
- PP242 demonstrated more potent inhibition of cell adhesion than rapamycin.
- mTORC1-mediated adhesion involves S6K1 and 4E-BP1 pathways, while mTORC2 acts via an Akt-independent mechanism.
Conclusions:
- Both mTORC1 and mTORC2 are critical regulators of cancer cell adhesion.
- mTORC1 controls cell adhesion through the S6K1 and 4E-BP1 signaling pathways.
- mTORC2 regulates cell adhesion independently of the Akt pathway.
More Related Videos
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
PI3K/mTOR/AKT Signaling Pathway
Intracellular Signaling Affects Focal Adhesions
Some...
Cell Adhesion Molecules - Types and Functions
CAM Families
The Integrin family of proteins is primarily involved...
Cell Adhesion Molecules - Types and Functions

